The G thats a bit rough If you go through year by year announcements you will notice the huge improvement in this company,m particularly since the new management has come in since 2008
Sure, they need money to survive and at 300k / month in costs they have 2 years worth in convertible notes Just go back and look at all the SPPs in the past
Indeed their costs run at a fifth of competitors at the same stage of evolution
There are a plethora of trials starting up - the momentum is forward
There is no other public viral cancer treatment shares in Australia
Being a suregon - I can tell you that viral oncogene treatment is looking very interesting
BD
VLA Price at posting:
71.0¢ Sentiment: ST Buy Disclosure: Held